The public defense of the doctoral thesis entitled "The effect of a single dose of the SGLT2 inhibitor, empagliflozin, on oxidative stress in patients undergoing elective coronary angiography" by Katica Cvitkušić Lukenda, MD, PhD, a doctoral student in Molecular Biosciences, will be held on July 28, 2025 at the Rectorate of the Josip Juraj Strossmayer University of Osijek, Hall 1, starting at 1:00 p.m.
The doctoral thesis was written under the mentorship of Assoc. Prof. Dr. Sc. Ivan Gudelj , Assistant Professor at the Department of Biotechnology, University of Rijeka, Mentor 1, and the Honorary Assoc. Prof. Dr. Sc. Ana Čipak Gašparović , Scientific Advisor at the Ruđer Bošković Institute and Associate Professor at the Josip Juraj Strossmayer University in Osijek.
Committee for Public Defense of the Doctoral Thesis:
- Prof. Dr. Kristina Selthofer-Relatić, full professor at the Faculty of Medicine Osijek, Josip Juraj Strossmayer University in Osijek, president;
- Assistant Professor Sandra Sobočanec, PhD , Senior Research Associate at the Ruđer Bošković Institute, member;
- Prof. Dr. Sc. Ivica Rubelj , permanent scientific advisor of the Ruđer Bošković Institute, member;
- Prof. Dr. Sc. Valentina Pavić , full professor at the Department of Biology, Josip Juraj Strossmayer University in Osijek, substitute member;
- Assoc. Prof. Dr. Sc. Ana Stupin, full professor at the Faculty of Medicine Osijek, Josip Juraj Strossmayer University in Osijek, substitute member.